Crohn Disease study: KleanLyte vs Bi-PegLyte
Official title Bowel Preparation for Colonoscopy Among Individuals With Crohn's and Ulcerative Colitis Disease.
ClinicalTrials.gov ID: NCT06298461
What this study is testing
What is KleanLyte?
KleanLyte is an investigational laxative being studied to see if it is a good way to clean the colon before a scope test for people with Crohn's disease. It is designed to pull water into the intestines to help flush out waste so the doctor can see the colon clearly.
Plain-language explanation of the investigational treatment. It is being studied and is not an approved or proven therapy. The study team can confirm the details.
- What it's testing
- This study wants to find out which of two different laxatives is more effective and easier to take before a colonoscopy.
- Who it's for
- The study is looking for adults who have Crohn's disease or ulcerative colitis.
- What's involved
- Participants will take one of two types of bowel-cleaning liquids and report how well it worked and how it felt.
- Time commitment
- The source text does not specify the total duration or number of visits required.
- Phase 4: studies an already-approved treatment
A plain-language read of the study's public ClinicalTrials.gov listing. The study team confirms the details.
Who can take part
Ages 18 and older
You may be able to join if
- Crohn's disease or ulcerative colitis patients scheduled or about to be scheduled for colonoscopy.
- Age \> 18 years
- Out-patients
You likely can't join if
- Prior subtotal or total colorectal resection
- Contraindications to use of 2L polyethylene glycol (2L-PEG) or Oral Sulfate Solution (OSS): Known renal insufficiency, congestive heart failure...
- Colonoscopy being repeated because of poor preparation in the preceding six months.
- Allergies to the employed bowel preparations
- Toxic megacolon, ileus, suspected or diagnosed bowel obstruction.
- IBD patients thought to be too sick to undergo a full colonoscopy preparation in the opinion of the investigator/treating physician
See the full eligibility criteria
- Crohn's disease or ulcerative colitis patients scheduled or about to be scheduled for colonoscopy.
- Age \> 18 years
- Out-patients
- Prior subtotal or total colorectal resection
- Contraindications to use of 2L polyethylene glycol (2L-PEG) or Oral Sulfate Solution (OSS): Known renal insufficiency, congestive heart failure, cirrhosis, severe electrolyte imbalance.
- Colonoscopy being repeated because of poor preparation in the preceding six months.
- Allergies to the employed bowel preparations
- Toxic megacolon, ileus, suspected or diagnosed bowel obstruction.
- IBD patients thought to be too sick to undergo a full colonoscopy preparation in the opinion of the investigator/treating physician; hospitalized crohn's disease or ulcerative colitis patients.
- Pregnancy
The study team makes the final eligibility decision.
Where it is enrolling
- Winnipeg, Manitoba, Canada
Questions & answers
Do participants get paid in this trial?
This listing doesn't specify compensation. Many trials still reimburse travel or offer a stipend, so it's worth asking the study team when you connect.
Is it free to join, and do I need insurance?
Searching and applying through BridgeMD is free. In clinical trials the study-related treatment and visits are generally provided at no cost to you. You usually don't need insurance to take part, but confirm specifics with the study team.
How long does this study last?
The listing doesn't state an exact length. The study team walks you through the schedule and number of visits before you decide to enroll.
Who can join this trial?
This study is enrolling all sexes, 18 years and older. The study team makes the final eligibility decision.
Where is this trial taking place?
This study is enrolling now at Winnipeg, Manitoba, Canada. Enter your location above to see the nearest enrolling site and check your eligibility.
Explore other conditions
BridgeMD is an information and trial-matching tool that is independent of the study sponsor. Details come from ClinicalTrials.gov. The study team decides eligibility, and your own doctor gives medical advice.